Tau protein aggregation: Key features to improve drug discovery screening
Johanna Giovannini, Willy Smeralda, Marie Jouanne, Jana Sopková‐de Oliveira Santos, Marco Catto, Anne Sophie Voisin‐Chiret
Topics & Concepts
TauopathyDrug discoveryTau proteinClinical trialNeuroscienceDiseaseIn silicoProtein aggregationDrugMedicineComputational biologyBioinformaticsAlzheimer's diseaseBiologyPharmacologyNeurodegenerationPathologyBiochemistryGeneAlzheimer's disease research and treatmentsComputational Drug Discovery MethodsCholinesterase and Neurodegenerative Diseases